Your browser is no longer supported. Please, upgrade your browser.
DaVita Inc.
IndexS&P 500 P/E18.07 EPS (ttm)6.57 Insider Own2.00% Shs Outstand120.91M Perf Week-4.15%
Market Cap13.12B Forward P/E14.42 EPS next Y8.24 Insider Trans-50.37% Shs Float108.69M Perf Month5.66%
Income832.10M PEG0.83 EPS next Q1.92 Inst Own97.90% Short Float4.78% Perf Quarter33.56%
Sales11.54B P/S1.14 EPS this Y28.30% Inst Trans-0.09% Short Ratio6.67 Perf Half Y39.53%
Book/sh13.02 P/B9.12 EPS next Y10.05% ROA4.70% Target Price109.90 Perf Year50.34%
Cash/sh6.61 P/C17.97 EPS next 5Y21.80% ROE43.30% 52W Range62.20 - 125.28 Perf YTD1.15%
Dividend- P/FCF8.71 EPS past 5Y6.60% ROI13.00% 52W High-5.21% Beta1.33
Dividend %- Quick Ratio1.30 Sales past 5Y-2.30% Gross Margin31.30% 52W Low90.92% ATR2.56
Employees65000 Current Ratio1.40 Sales Q/Q0.70% Oper. Margin14.60% RSI (14)56.88 Volatility2.12% 2.05%
OptionableYes Debt/Eq5.10 EPS Q/Q29.00% Profit Margin7.30% Rel Volume0.89 Prev Close119.64
ShortableYes LT Debt/Eq5.00 EarningsOct 29 AMC Payout0.00% Avg Volume779.28K Price118.75
Recom2.80 SMA200.78% SMA506.39% SMA20032.00% Volume692,558 Change-0.74%
Jan-05-21Downgrade BofA Securities Buy → Neutral $127
Jan-24-20Upgrade Goldman Neutral → Buy $72 → $97
Nov-07-19Downgrade Raymond James Outperform → Mkt Perform
Oct-25-19Downgrade Wolfe Research Outperform → Peer Perform
Sep-11-19Downgrade William Blair Outperform → Mkt Perform
Jul-26-19Downgrade Robert W. Baird Outperform → Neutral $70 → $65
Jan-08-19Upgrade UBS Sell → Neutral
Jan-03-19Initiated Deutsche Bank Buy $60
Dec-14-18Initiated Barclays Overweight
Nov-28-18Upgrade Raymond James Mkt Perform → Outperform
Nov-16-18Initiated UBS Sell $64
Nov-08-18Downgrade Raymond James Strong Buy → Mkt Perform
Sep-13-18Upgrade JP Morgan Underweight → Neutral
Jan-04-18Upgrade BofA/Merrill Neutral → Buy
Dec-12-17Upgrade Robert W. Baird Neutral → Outperform $63 → $82
Dec-11-17Upgrade Citigroup Neutral → Buy
Dec-07-17Upgrade Raymond James Outperform → Strong Buy
Nov-08-17Reiterated RBC Capital Mkts Sector Perform $64 → $60
Oct-09-17Downgrade JP Morgan Neutral → Underweight
Jun-26-17Downgrade Jefferies Buy → Hold
Jan-05-21 12:18PM  
Jan-04-21 09:26AM  
Dec-31-20 11:50AM  
Dec-29-20 11:40AM  
Dec-28-20 12:18PM  
Dec-25-20 07:50AM  
Dec-23-20 01:45PM  
Dec-22-20 10:38AM  
Dec-21-20 08:35PM  
Dec-17-20 12:56PM  
Dec-15-20 11:50AM  
Dec-14-20 12:46PM  
Dec-11-20 12:55PM  
Dec-10-20 11:40AM  
Dec-07-20 01:16AM  
Nov-27-20 11:50AM  
Nov-25-20 06:46AM  
Nov-24-20 11:40AM  
Nov-23-20 06:04AM  
Nov-20-20 09:02AM  
Nov-19-20 07:54AM  
Nov-17-20 08:48AM  
Nov-16-20 11:30AM  
Nov-11-20 11:50AM  
Nov-10-20 10:24AM  
Nov-06-20 11:40AM  
Nov-05-20 11:00AM  
Nov-04-20 12:21PM  
Nov-03-20 01:53PM  
Nov-02-20 08:07AM  
Nov-01-20 09:29AM  
Oct-30-20 03:01PM  
Oct-29-20 05:35PM  
Oct-28-20 12:26PM  
Oct-26-20 11:50AM  
Oct-22-20 12:34PM  
Oct-21-20 11:40AM  
Oct-20-20 08:01AM  
Oct-19-20 08:49AM  
Oct-15-20 04:52PM  
Oct-14-20 09:23AM  
Oct-13-20 08:37AM  
Oct-09-20 11:50AM  
Oct-08-20 11:30AM  
Oct-07-20 07:56AM  
Oct-05-20 11:40AM  
Oct-01-20 09:58AM  
Sep-27-20 09:44AM  
Sep-26-20 10:30AM  
Sep-25-20 01:52PM  
Sep-24-20 08:48AM  
Sep-23-20 11:50AM  
Sep-22-20 01:16PM  
Sep-21-20 01:33PM  
Sep-18-20 11:40AM  
Sep-17-20 09:15AM  
Sep-16-20 06:27PM  
Sep-15-20 06:30AM  
Sep-10-20 10:11AM  
Sep-09-20 08:33AM  
Sep-08-20 02:04PM  
Sep-07-20 11:50AM  
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services; vascular access services; clinical research programs; physician services; and comprehensive care services. As of December 31, 2019, it provided dialysis and administrative services in the United States through a network of 2,753 outpatient dialysis centers serving approximately 206,900 patients; and operated 259 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 28,700 patients. Further, the company provides acute inpatient dialysis services in approximately 900 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was founded in 1994 and is headquartered in Denver, Colorado.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DIAZ PAUL JDirectorNov 30Option Exercise68.7019,3581,329,92318,877Dec 02 06:31 PM
STAFFIERI MICHAEL DAVIDChief Operating Officer, DKCNov 30Sale109.7425,0002,743,51542,431Dec 02 06:31 PM
Arway Pamela MDirectorNov 20Sale107.8843046,38819,239Nov 23 07:22 PM
STAFFIERI MICHAEL DAVIDChief Operating Officer, DKCNov 18Option Exercise69.9267,1004,691,908132,576Nov 19 07:24 PM
STAFFIERI MICHAEL DAVIDChief Operating Officer, DKCNov 17Option Exercise75.4236,4772,751,095121,703Nov 19 07:24 PM
DESOER BARBARA JDirectorNov 17Sale111.001,388154,068430Nov 17 09:17 PM
Arway Pamela MDirectorNov 16Option Exercise68.7019,3581,329,92331,292Nov 17 09:15 PM
Arway Pamela MDirectorNov 16Sale111.637,326817,80119,669Nov 17 09:15 PM
DESOER BARBARA JDirectorNov 11Option Exercise68.173,816260,1533,816Nov 13 06:29 PM
Waters Kathleen AlyceChief Legal OfficerNov 10Sale105.0110,0001,050,12955,874Nov 12 06:17 PM
NEHRA JOHN MDirectorSep 23Buy82.952,500207,3745,500Sep 24 06:22 PM
NEHRA JOHN MDirectorSep 22Buy84.603,000253,8143,000Sep 24 06:22 PM
ZUMWALT LEANNE MGroup VP, Government AffairsSep 18Option Exercise72.6036,9232,680,72151,049Sep 22 07:59 PM
ZUMWALT LEANNE MGroup VP, Government AffairsSep 18Sale88.033,772332,03124,590Sep 22 07:59 PM
WESCHLER, R. TEDMember of 10% owner groupSep 17Sale88.002,000,000176,000,00036,095,570Sep 21 04:38 PM
WESCHLER, R. TEDMember of 10% owner groupSep 17Sale88.00200,00017,600,0001,991,806Sep 21 04:38 PM
Arway Pamela MDirectorAug 24Sale87.0257850,29819,239Aug 25 05:56 PM
BERG CHARLESDirectorJun 08Option Exercise81.514,662380,00015,666Jun 10 06:21 PM
DIAZ PAUL JDirectorJun 08Option Exercise81.514,662380,00010,598Jun 10 06:22 PM
ROPER WILLIAM LDirectorJun 08Option Exercise81.514,662380,00020,623Jun 10 06:21 PM
Arway Pamela MDirectorJun 08Option Exercise81.514,662380,00023,901Jun 10 06:21 PM
NEHRA JOHN MDirectorJun 08Option Exercise81.514,662380,0004,662Jun 10 06:22 PM
GRAUER PETER TDirectorJun 08Option Exercise71.1935,0832,497,46883,790Jun 10 06:23 PM
Arway Pamela MDirectorJun 08Sale87.3235731,17419,239Jun 10 06:21 PM
ROPER WILLIAM LDirectorJun 08Sale86.7935730,98315,961Jun 10 06:21 PM
BERG CHARLESDirectorJun 08Sale87.5335731,24911,004Jun 10 06:21 PM
Arway Pamela MDirectorMay 22Sale78.9059947,26119,239May 27 04:05 PM
DIAZ PAUL JDirectorMay 18Sale82.225,763473,8259,986May 19 09:19 PM
THIRY KENT JExecutive ChairmanMay 12Sale80.8962,0005,015,000548,653May 13 08:47 PM
THIRY KENT JExecutive ChairmanMay 11Option Exercise75.42145,52210,975,269283,369May 13 08:47 PM
THIRY KENT JExecutive ChairmanMay 11Sale81.2862,0005,039,391610,653May 13 08:47 PM
THIRY KENT JExecutive ChairmanMay 11Sale81.185,390437,537137,847May 13 08:47 PM
Arway Pamela MDirectorMar 20Sale71.2562544,53119,239Mar 24 06:42 PM
NEHRA JOHN MDirectorMar 02Sale80.747,694621,21454,759Mar 04 07:11 PM
NEHRA JOHN MDirectorFeb 27Sale80.4911,806950,26562,453Feb 28 07:07 PM
NEHRA JOHN MDirectorFeb 26Sale80.9320,0001,618,60074,259Feb 28 07:07 PM